INVIVYD, INC. Sale Leaseback Transaction, Monthly Rental Payments
INVIVYD, INC. (IVVD) reported Sale Leaseback Transaction, Monthly Rental Payments of $700.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Financial Statements › Notes › Leases
us-gaap:SaleLeasebackTransactionMonthlyRentalPayments · last filed 2026-08-13
- 2023-09-30: Sale Leaseback Transaction, Monthly Rental Payments 9 month $700.00K.
- 2022-09-30: Sale Leaseback Transaction, Monthly Rental Payments $1.30M.
- 2022-06-30: Sale Leaseback Transaction, Monthly Rental Payments $1.30M; Sale Leaseback Transaction, Monthly Rental Payments as first filed $700.00K.
- 2021-09-30: Sale Leaseback Transaction, Monthly Rental Payments 1 month $400.00K.
| Period end | Sale Leaseback Transaction, Monthly Rental Payments | Sale Leaseback Transaction, Monthly Rental Payments as first filed | Sale Leaseback Transaction, Monthly Rental Payments 1 month | Sale Leaseback Transaction, Monthly Rental Payments 9 month |
|---|---|---|---|---|
| 2023-09-30 | $700.00K 10-Q · filed 2023-11-09 | |||
| 2022-09-30 | $1.30M 10-Q · filed 2024-05-09 | |||
| 2022-06-30 | $1.30M 10-Q · filed 2026-08-13 | $700.00K 10-K · filed 2023-03-23 | ||
| 2021-09-30 | $400.00K 10-Q · filed 2025-11-06 | |||
| 2021-09-14 | $400.00K 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |